About this trial
The study is to evaluate effectiveness of one-level versus two-level thoracic ESP block on intraoperative and postoperative analgesia in bariatric surgeries and to compare total opioid consumption of both groups.
Eligibility criteria
Qualifiers
Patient age ranges 18 to 60 years old
Obese patients ; Body mass index(BMI) ≥ 35 - 50 kg/m2
American Society of Anesthesiologists (13) physical status classes II to III
Patients scheduled for laparoscopic bariatric surgery i.e. sleeve gastrectomy and/or Roux-en-Y gastric bypass (RYGB) surgeries
Disqualifiers
• Refusal of regional block
Patients with neurological, psychological disorders or those lacking cooperation.
Patients scheduled for concomitant laparoscopic cholecystectomy or paraumbilical hernia repair or those with history of previous bariatric surgery or obstructive sleep apnea.
Patients with anatomic abnormalities at site of injection, skin lesions or wounds at site of proposed needle insertion.
Trial design
Treatments tested in this trial
- one level ESPB
- two level ESPB